EssilorLuxottica/€EL
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About EssilorLuxottica
EssilorLuxottica is a French-Italian multinational corporation operating in the eyewear and eye care industry. It was formed through the merger of the French ophthalmic optics company Essilor and the Italian eyewear company Luxottica in 2018. The company designs, manufactures, and distributes ophthalmic lenses, optical equipment, and eyewear, including well-known brands such as Ray-Ban, Oakley, and Persol, as well as licensed brands like Chanel and Prada. Headquartered in Charenton-le-Pont, France, and Milan, Italy, EssilorLuxottica has a global presence with operations in over 150 countries. Its strategic positioning is underscored by its integrated business model that encompasses both retail and wholesale distribution, leveraging its extensive portfolio of proprietary and licensed brands.
- Ticker
- €EL
- Sector
- Health
- Primary listing
- PAR
- Employees
- 213,909
- Headquarters
- Paris, France
- Website
- www.essilorluxottica.com
EssilorLuxottica Metrics
BasicAdvanced
€80B
32.50
€5.35
0.55
€4.00
2.30%
Price and volume
Market cap
€80B
Beta
0.55
52-week high
€322.60
52-week low
€138.00
Average daily volume
850K
Dividend rate
€4.00
Financial strength
Current ratio
0.889
Quick ratio
0.469
Long term debt to equity
0.242
Total debt to equity
0.384
Dividend payout ratio (TTM)
66.92%
Interest coverage (TTM)
10.55%
Profitability
EBITDA (TTM)
5,899
Gross margin (TTM)
60.02%
Net profit margin (TTM)
8.52%
Operating margin (TTM)
12.87%
Effective tax rate (TTM)
23.99%
Revenue per employee (TTM)
€140,000
Management effectiveness
Return on assets (TTM)
3.71%
Return on equity (TTM)
6.72%
Valuation
Price to earnings (TTM)
32.495
Price to revenue (TTM)
2.74
Price to book
2.04
Price to tangible book (TTM)
-34.45
Price to free cash flow (TTM)
20.888
Free cash flow yield (TTM)
4.79%
Free cash flow per share (TTM)
8.325
Dividend yield (TTM)
2.30%
Forward dividend yield
2.30%
Growth
Revenue change (TTM)
7.50%
Earnings per share change (TTM)
3.85%
3-year revenue growth (CAGR)
4.93%
10-year revenue growth (CAGR)
15.57%
3-year earnings per share growth (CAGR)
0.81%
10-year earnings per share growth (CAGR)
3.98%
3-year dividend per share growth (CAGR)
7.39%
10-year dividend per share growth (CAGR)
13.68%
What the Analysts think about EssilorLuxottica
Analyst ratings (Buy, Hold, Sell) for EssilorLuxottica stock.
Analyst projections of the future price of EssilorLuxottica stock.
Bulls say / Bears say
Third-quarter revenue rose 7.2% at constant currency to €7.49 billion, beating forecasts, as traditional eyewear helped offset slower smart-glasses growth. The core business remains a strong source of growth. (Financial Times)
EssilorLuxottica and Meta expanded the range with camera-free AI glasses, a new Ray-Ban Meta generation and launches in more markets. A broader line-up gives the partnership more ways to reach customers. (EssilorLuxottica)
First-half adjusted operating profit rose 15% and comfortably beat analysts’ expectations. Stronger price and product mix contributed to the improvement, alongside tariff refunds. (Reuters)
Wearables revenue growth slowed to 20% in the third quarter, from nearly 100% in the second. The harder comparison with last year could make growth harder to sustain near term. (Reuters)
Privacy scrutiny could limit where camera-equipped glasses can be used or sold. European privacy regulators raised concerns about covert recording, while Norway said it planned a temporary ban in selected locations. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 21 Oct 2026.
EssilorLuxottica Financial Performance
Revenues and expenses
EssilorLuxottica Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing EssilorLuxottica
AllEURUSDGBP
Fund name | Fund size | €EL weighting |
|---|---|---|
Amundi CAC 40€C40 | €999M | 4.91% |
iShares STOXX Europe 600 Health Care€EXV4 | €709M | 2.76% |
iShares MSCI Europe Health Care Sector€ESIH | €890M | 2.67% |
iShares MSCI Europe Health Care Sector£ESIH | €890M | 2.67% |
iShares MSCI Europe SRI£IESG | €3.2B | 1.89% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.